Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription 22.06.2026 1 AJR Am J Roentgenol 1 Am J Clin Pathol 2 BJU Int 1 BMC Cancer 2 Cancer 1 Cancer Res 2 Clin Cancer Res 1 Endocrinology 1 Eur J Radiol 4 Eur Urol 1 Int J Urol 2 J Magn Reson Imaging 1 Magn Reson Med 2 Oncogene 1 PLoS One 1 Proc Natl Acad Sci U S A 2 Prostate 1 Radiol Imaging Cancer 1 Semin Radiat Oncol 1 Urol Int

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. SARI ZNA, Bezuidenhout AF, Delgado N, Sari L, et al
   Prostate Feeding Artery on MRI: Association With Clinically Significant Prostate Cancer.
   AJR Am J Roentgenol. 2026 Jun 17. doi: 10.2214/AJR.26.35035.
   PubMed        
   
   

   
   Am J Clin Pathol

2. TANG M, Xie C, Huang R, Lei C, et al
   MYC gene amplification drives protein overexpression and its clinical prognostic value in prostate cancer: a study of 152 Chinese cases.
   Am J Clin Pathol. 2026;165:aqag059.
   PubMed         Abstract available
   
   

   
   BJU Int

3. WESSENDORF MP, Mangold MH, Baumann G, Winter N, et al
   Structured micro-ultrasonography training improves prostate cancer detection and management decisions.
   BJU Int. 2026 Jun 18. doi: 10.1111/bju.70360.
   PubMed         Abstract available
   
   
4. FINOCCHIARO A, Aljoulani M, Almajedi M, Silvia V, et al
   The impact of prostate size on single-port robot-assisted radical prostatectomy surgical outcomes.
   BJU Int. 2026;138:100-107.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. OKSUZ S, Kinikoglu O, Sariyar N, Ozdemir M, et al
   Prognostic value of PSA Kinetic Ratio in high-volume mCSPC patients treated with abiraterone or enzalutamide: a single-center retrospective study.
   BMC Cancer. 2026;26:728.
   PubMed         Abstract available
   
   

   
   Cancer

6. MCKAY RR, Xie W, Ajmera A, Araneta A, et al
   Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.
   Cancer. 2026;132:e70496.
   PubMed         Abstract available
   
   
7. CHENG Y, Huang H, Wang M, Zhu L, et al
   Magnetic resonance imaging-targeted biopsy with index lesion ipsilateral or bilateral systematic biopsy in prostate cancer: A multicenter, paired, noninferiority, observational trial.
   Cancer. 2026;132:e70493.
   PubMed         Abstract available
   
   

   
   Cancer Res

8. SIDDIQUI NA, Zhang L, DeLeon G, Naguib N, et al
   Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer.
   Cancer Res. 2026 Jun 15. doi: 10.1158/0008-5472.CAN-25-4954.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

9. LEE PC, Schweizer MT, Nadal R
   Piggybacking Towards Progress for CAR-T Cell Therapy in Prostate Cancer.
   Clin Cancer Res. 2026 Jun 17. doi: 10.1158/1078-0432.CCR-26-0959.
   PubMed         Abstract available
   
   
10. CHAUHAN PS, Pachynski RK, Maher CA, Chaudhuri AA, et al
    AR and Beyond: ctDNA Maps Resistance Evolution in mCRPC.
    Clin Cancer Res. 2026;32:2323-2325.
    PubMed         Abstract available
    
    

    
    Endocrinology

11. QI S, Dehm SM
    3D Genome Architecture and Epigenetic Regulation of Lineage Identity in Advanced Prostate Cancer.
    Endocrinology. 2026 Jun 17:bqag068. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    Eur J Radiol

12. SINGH D, Salazar Gutierrez JP, Rouviere O, Giganti F, et al
    Use of Artificial Intelligence in prostate MRI: A rapid scoping review highlighting limited evidence in screening context.
    Eur J Radiol. 2026;202:112930.
    PubMed         Abstract available
    
    

    
    Eur Urol

13. SOORIAKUMARAN P, Bryant RJ, Hamdy FC
    Radical Prostatectomy in Low-volume Metastatic Prostate Cancer? The Need for New Evidence.
    Eur Urol. 2026 Jun 12:S0302-2838(26)02213-X. doi: 10.1016/j.eururo.2026.
    PubMed        
    
    
14. YUSUF S, Azam A, Sood I, Al-Sattar H, et al
    Re: Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP Trial.
    Eur Urol. 2026 Jun 16:S0302-2838(26)02185-8. doi: 10.1016/j.eururo.2026.
    PubMed        
    
    
15. FRANCINI E
    Re: Final Overall Survival Results from EORTC 1333/PEACE-3 Trial of Enzalutamide plus Radium-223 in Metastatic Castration-resistant Prostate Cancer.
    Eur Urol. 2026 Jun 16:S0302-2838(26)02175-5. doi: 10.1016/j.eururo.2026.
    PubMed        
    
    
16. DAVIS ID
    Re: Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.
    Eur Urol. 2026 Jun 17:S0302-2838(26)02177-9. doi: 10.1016/j.eururo.2026.
    PubMed        
    
    

    
    Int J Urol

17. TOHI Y, Merseburger AS, Sugimoto M
    Editorial Comment on to Investigate Disparities in Strategies for Low-Risk Prostate Cancer by Facility Type Using the Japan Study Group of Prostate Cancer Database.
    Int J Urol. 2026;33:e70440.
    PubMed        
    
    

    
    J Magn Reson Imaging

18. FU X, Bao J, Qiao X, Shen J, et al
    Navigating Uncertainty in MRI Diagnosis: A Human-AI Collaborative Strategy for Stratifying Clinically Significant Prostate Cancer.
    J Magn Reson Imaging. 2026 Jun 16. doi: 10.1002/jmri.70393.
    PubMed         Abstract available
    
    
19. LI K, Mi S, Chen L, Jiang M, et al
    AI-Assisted Prostate Cancer Diagnosis Using Biparametric MRI and PI-RADS v2.1: Performance Comparison Between Novice-Level and Experienced Readers.
    J Magn Reson Imaging. 2026 Jun 17. doi: 10.1002/jmri.70411.
    PubMed         Abstract available
    
    

    
    Magn Reson Med

20. ABBAS M, Zhou W, Maier SE, Langkilde F, et al
    Self-Supervised Deep Learning Framework for Rician Distribution Based Denoising and Modeling of Multi-b Prostate Diffusion MRI.
    Magn Reson Med. 2026;96:928-942.
    PubMed         Abstract available
    
    

    
    Oncogene

21. HODGSON K, Orozco-Moreno M, Peng Z, Blencoe L, et al
    The glycobiology of prostate cancer: an update.
    Oncogene. 2026 Jun 18. doi: 10.1038/s41388-026-03858.
    PubMed         Abstract available
    
    
22. LIAO Y, Sun W, Li Y, Deng Y, et al
    The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1.
    Oncogene. 2026;45:2405-2418.
    PubMed         Abstract available
    
    

    
    PLoS One

23. DE JONG-ULTEE SM, de Waard L, van Staalduinen DJ, Mosselman MJ, et al
    Professionals' perceptions of interprofessional collaboration within condition-based units.
    PLoS One. 2026;21:e0343792.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

24. WU X, Song X, Li B, Yang Y, et al
    Targeting the DNA methylation-H3K27me3 switch reverses castration resistance and immunosuppression via ADAMTS1-driven collagenolysis.
    Proc Natl Acad Sci U S A. 2026;123:e2525431123.
    PubMed         Abstract available
    
    

    
    Prostate

25. YAZGAN SC, Yekeduz E, Urun Y
    Insights and Limitations in Evaluating Testosterone Recovery With LHRH Antagonists and Agonists.
    Prostate. 2026 May 3. doi: 10.1002/pros.24904.
    PubMed         Abstract available
    
    
26. EROGLU A, Gezmis CT, Arikan Y, Cilesiz NC, et al
    Hematological Inflammation Markers in the Prediction of Clinically Significant Prostate Cancer and the Individualization of Biopsy Decisions for PI-RADS 3 Lesions: A Two-Center Retrospective Study.
    Prostate. 2026 Jun 18. doi: 10.1002/pros.70210.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

27. ULANER GA, Parihar AS, Calais J, Sutcliffe S, et al
    Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis.
    Radiol Imaging Cancer. 2026;8:e250732.
    PubMed         Abstract available
    
    

    
    Semin Radiat Oncol

28. LIOU KT, Metri NA, Newton RU, Ajay D, et al
    Integrative Oncology for Prostate Cancer: A Narrative Review.
    Semin Radiat Oncol. 2026;38:151031.
    PubMed         Abstract available
    
    

    
    Urol Int

29. SHEN B, Wang F
    Precision Nodal Staging in Intermediate-Risk Prostate Cancer: A Narrative Review of Molecular Imaging.
    Urol Int. 2026 Jun 12:1-19. doi: 10.1159/000552660.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum